Clinical Trials Directory

Trials / Completed

CompletedNCT04771624

Assessment of Executive Functions After Covid-19

May Covid-19 Impair Executive Functions? A Crossectional Study

Status
Completed
Phase
Study type
Observational
Enrollment
128 (actual)
Sponsor
Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

As it is evident that Covid-19 may have some impacts on cognition, the primary aim of this study is to investigate -if any- deficits of attention, working memory and executive functions after Covid-19.

Detailed description

Since Covid-19 (Coronavirus Disease-2019) was declared as a pandemic by the World Health Organization (WHO) on December 31, 2019, it is still widespread and deadly. As an ongoing pandemic, it has led to a panic and then a controlled fear in societies. In many studies, neuropsychological deficits were observed in Covid-19 patients both during the illness and after recovery. A recent study found that impairment in cognitive functions continued after recovery of Covid-19, and it was associated with peripherical inflammatory markers, such as C-Reactive Protein (CRP). CRP, as a peripherical inflammatory marker, has been proven to be inversely related to serum levels of the brain-derived neurotrophic factor (BDNF), an important neurotrophin in the growth and differentiation of neurons. In this study, attention, working memory and executive functions of Covid-19 patients at post-covid period and its relation with the severity of the disease will be investigated.

Conditions

Timeline

Start date
2020-10-30
Primary completion
2021-04-30
Completion
2021-11-01
First posted
2021-02-25
Last updated
2021-11-09

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT04771624. Inclusion in this directory is not an endorsement.